非复制型痘苗病毒载体 non-replicating vaccinia virus vector
在艾滋病疫苗中拓展并合理利用载体可以优化疫苗，而弄清复制型载体与非复制型载体之间的优先次序问题也十分关键。
In the AIDS vaccine development and the rational use of vector vaccine can be optimized, and copy out-Carrier and non-replicating vector between the priorities is very critical.
默克疫苗的失败至多代表非复制型腺病毒载体疫苗的失败，决不代表其他艾滋病疫苗就没有希望。
The failure of the Merck vaccine up on behalf of the non-replicating adenovirus vector vaccine failure, not on behalf of other AIDS vaccines will be no hope.
应用推荐